Christopher Halloran

10.0k citations

76 papers · 2.6k indexed · 2 hit papers · h-index 25

Impact in

Oncology top 1%
- Pancreatic and Hepatic Oncology Research
Surgery top 2%
- Pancreatitis Pathology and Treatment
- Gastrointestinal disorders and treatments
- Cholangiocarcinoma and Gallbladder Cancer Studies

Papers in

Oncology 61
- Pancreatic and Hepatic Oncology Research 59
Surgery 39
- Pancreatitis Pathology and Treatment 33
- Gastrointestinal disorders and treatments 7

Co-authors: John P. Neoptolemos Paula Ghaneh Robert Sutton Michael Raraty Eithne Costello William Greenhalf Peter Szatmary N. Alexakis
Journals: Pancreatology (13 papers)Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)Langenbeck s Archives of Surgery (3 papers)British journal of surgery (3 papers)
Partner nations: United Kingdom Germany United States

In The Last Decade

Christopher Halloran

72 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Acute Pancreatitis: Diagnosis and Treatment 2022 · 263 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Drugs
2020 The Lancet. Gastroenterology & hepatology

Peers

Countries citing papers authored by Christopher Halloran

Since Specialization

Citations

This map shows the geographic impact of Christopher Halloran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Halloran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Halloran more than expected).

Fields of papers citing papers by Christopher Halloran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Halloran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Halloran. The network helps show where Christopher Halloran may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher Halloran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Halloran Line = papers co-authored together Christopher Halloran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes JAMA Network Open ·A Puca, ningqi zhu, Lucy Oldfield, D.S. McConville, Robert N. Hanson, Daniel H. Palmer, Christopher Halloran, William Greenhalf, Robert Van Der Meer, Eithne Costello	2025	0
2	Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis Cancer Research ·Manel Chnayna, Youness Kadil, Lucy Ireland, Mark Glenn, Nobuo Nagai, Sylvia M. Bagett, Christopher Halloran, Paula Ghaneh, Robert Jones, Michael C. Schmid, Ainhoa Mielgo	2024	19
3	Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer Nature Communications ·Meirion Raymant, Yuliana Astuti, Young-Jae Kim, Daniel M. Green, Valeria Quaranta, Nobuo Nagai, Mark Glenn, Lütfi İhsan SEZER, Daniel H. Palmer, Christopher Halloran, Paula Ghaneh, Neil C. Henderson, Jennifer P. Morton, Manuel Valiente, Ainhoa Mielgo, Michael C. Schmid	2024	37
4	Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis Nature Cancer ·Yuliana Astuti, Meirion Raymant, Valeria Quaranta, Kim Clarke, Youness Kadil, Olivia Smith, Nobuo Nagai, Lütfi İhsan SEZER, Craig Nourse, Christopher Halloran, Paula Ghaneh, Daniel H. Palmer, Robert Jones, Fiona Campbell, Jeffrey W. Pollard, Jennifer P. Morton, Ainhoa Mielgo, Michael C. Schmid	2024	42
5	Abstract PR02: Deep proteomics identifies novel biomarker candidates and molecular pathways of pancreatic cancer-related diabetes Cancer Research ·Lucy Oldfield, Emily Johnson, Yogesh J Patwala, D.S. McConville, William Greenhalf, Christopher Halloran, Eithne Costello	2024	1
6	Genetic and functional analysis of chymotrypsin-like protease (CTRL) in chronic pancreatitis Pancreatology ·Mykhailo Parkhomchuk, Jucineth Glória do Espírito Santo Vital de Carvalho, 符岳全, Masamichi Sato, Jocelyn Coates, Emmanuelle Masson, Jian‐Min Chen, Claude Férec, Vinciane Rebours, Tassos Grammatikopoulos, Pierre Foskett, William Greenhalf, Christopher Halloran, John P. Neoptolemos, Tobias B. Haack, Stephan Ossowski, Marc Sturm, Jonas Rosendahl, Helmut Laumen, Heiko Witt	2023	2
7	Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes EBioMedicine ·Lucy Oldfield, A.G. Evans, De Luyck, Claire Jenkinson, Tejpal Purewal, Eftychia Eirini Psarelli, Usha Menon, John F. Timms, Stephen P. Pereira, Paula Ghaneh, William Greenhalf, Christopher Halloran, Eithne Costello	2022	23
8	Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis Gut ·Nobuo Nagai, Carolyn Rainer, Valeria Quaranta, Yuliana Astuti, Meirion Raymant, N. H. Patil, Sylvia M. Bagett, Fiona Campbell, Paula Ghaneh, Christopher Halloran, Dean E. Hammond, Jennifer P. Morton, Daniel H. Palmer, С П Ситько, Robert Jones, Ainhoa Mielgo, Michael C. Schmid	2022	71
9	United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer BMJ Open ·Lucy Oldfield, D.S. McConville, Robert N. Hanson, Richard Jackson, William F. Reynolds, Lütfi İhsan SEZER, Robert Van Der Meer, Laurence Alison, Ricardo Tejeiro, Tejpal Purewal, Paula Ghaneh, Daniel H. Palmer, William Greenhalf, Christopher Halloran, Eithne Costello	2022	10
10	Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties Cancer Research ·Lawrence N. Barrera, A.G. Evans, Brian R. Lane, 禎子渡辺, LI Yaqu, Fiona Campbell, Timothy Andrews, Zipeng Lu, Pedro A. Pérez–Mancera, Triantafillos Liloglou, Milton Ashworth, Vincentia Tri H, Nataliia M. Yeftieni, Quentin Nunes, Phoebe A. Phillips, John F. Timms, Christopher Halloran, William Greenhalf, John P. Neoptolemos, Eithne Costello	2020	25
11	Prognostic value of 18FDG PET/CT volumetric parameters in the survival prediction of patients with pancreatic cancer European Journal of Surgical Oncology ·Panichkriangkrai, Tatiana Linhares, Eftychia Eirini Psarelli, Luan A Kickhofel, Sobhan Vinjamuri, Bal Sanghera, Wai Lup Wong, Christopher Halloran, Paula Ghaneh	2020	12
12	Pancreas‐specific plasma amylase for assessment and diagnosis of chronic pancreatitis: New insights on an old topic United European Gastroenterology Journal ·Søren Schou Olesen, Henrik Krarup, Jakob Lykke Poulsen, Jeppe Hagstrup Christensen, Andrea Sheel, Robert Sutton, William Greenhalf, Christopher Halloran, Asbjørn Mohr Drewes	2019	14
13	Natural history of SPINK1 germline mutation related-pancreatitis EBioMedicine ·Nelly Müller, Ioannis Sarantitis, Marie Rouanet, Louis de Mestier, Christopher Halloran, William Greenhalf, Claude Férec, Emmanuelle Masson, Philippe Ruszniewski, Philippe Lévy, John P. Neoptolemos, Louis Buscail, Vinciane Rebours	2019	45
14	The diagnostic value of Rosemont and Japanese diagnostic criteria for ‘indeterminate’, ‘suggestive’, ‘possible’ and ‘early’ chronic pancreatitis Pancreatology ·Andrea Sheel, Ryan Baron, Ioannis Sarantitis, Jayapal Ramesh, Paula Ghaneh, Michael Raraty, Vincent Yip, Robert Sutton, Pongsathorn Asavatheputhai, Fiona Campbell, Verónica Simbaña, Priya Healey, Richard Jackson, Christopher Halloran, John P. Neoptolemos	2018	19
15	A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous Surgical Endoscopy ·一仁鍋島, Jayapal Ramesh, Silvia Cicconi, Jonathan Evans, Vincent Yip, Michael Raraty, Paula Ghaneh, Robert Sutton, John P. Neoptolemos, Christopher Halloran	2018	41
16	PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial Trials ·Christopher Halloran, Khaled Zaatouri, Zheng XiaoYan, Johanna Soet Buzolitz, Derek O’Reilly, Dhanny Gomez, Andrew M. Smith, John P. Neoptolemos, Masato Nakayama, Mark Taylor, Jane Blazeby, Paula Ghaneh	2016	24
17	Adjuvant Therapy in Pancreatic Cancer LI Yaqu, Paula Ghaneh, Richard E. Jackson, Christopher Halloran	2015	17
18	PTH-095 Portal Hypertension Due To Splanchnic Venous Thrombosis Following Open Or Skunk Wire Necrosectomy Of Acute Severe Pancreatitis Gut ·Handi Lv, Tsai Chun Bin, D. Grtdd, Christopher Halloran, Anna Schultz	2014	1
19	Incidence of Post-ERCP Pancreatitis From Direct Pancreatic Juice Collection in Hereditary Pancreatitis and Familial Pancreatic Cancer Before and After the Introduction of Prophylactic Pancreatic Stents and Rectal Diclofenac Pancreas ·James Nicholson, William Greenhalf, Richard Jackson, Trevor F. Cox, Jane Butler, I. Helling, Sara Harrison, 周养德, Christopher Halloran, Martina Štecherová, Michael Raraty, Paula Ghaneh, Marianne Johnstone, Sanchoy Sarkar, Howard Smart, Jonathan Evans, Guruprasad P. Aithal, Robert Sutton, John P. Neoptolemos, Martin Lombard	2014	4
20	Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D₁receptor agonist sensitization The Journal of Comparative Neurology ·Sophia T. Papadeas, Christopher Halloran, Thomas J. McCown, George R. Breese, Bonita L. Blake	2008	9

About Christopher Halloran

Christopher Halloran is a scholar working on Oncology, Surgery, Cancer Research, Biotechnology and Pulmonary and Respiratory Medicine, having authored 76 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (59 papers), Pancreatitis Pathology and Treatment (33 papers), Cancer Genomics and Diagnostics (10 papers), Gastrointestinal disorders and treatments (7 papers), Metabolism, Diabetes, and Cancer (7 papers), Gastric Cancer Management and Outcomes (6 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Oncology (1.8k citations), Surgery (1.5k citations), Cancer Research (374 citations), Pulmonary and Respiratory Medicine (488 citations) and Gastroenterology (74 citations). Christopher Halloran has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include John P. Neoptolemos, Paula Ghaneh, Robert Sutton, Michael Raraty, Eithne Costello, William Greenhalf, Peter Szatmary, N. Alexakis, Tassos Grammatikopoulos and Wei Huang. Their work appears in journals such as Pancreatology, Cancer Research, Journal of Clinical Oncology, Langenbeck s Archives of Surgery and British journal of surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact